Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2001
11/01/2001WO2001060381B1 Nucleoside analogs with carboxamidine-modified bicyclic base
11/01/2001WO2001042231A3 Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors
11/01/2001WO2001041762A3 Valdecoxib compositions
11/01/2001WO2001041761A3 Valdecoxib compositions
11/01/2001WO2001038311A3 Pyrimidine derivatives as selective inhibitors of cox-2
11/01/2001WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof
11/01/2001WO2001034640A3 Peptide (virip) which inhibits a circulating virus in humans and the use thereof
11/01/2001WO2001032866A3 Hybrid adaptor receptors
11/01/2001WO2001029049A3 Imidazole derivatives as phosphodiesterase vii inhibitors
11/01/2001WO2001029025A3 Tyrosine kinase inhibitors
11/01/2001WO2001018161A3 Process for the preparation of conjugated linoleic acid (cla)
11/01/2001WO2001014318A3 New effectors of dipeptidyl peptidase iv for topical use
11/01/2001WO2001012233A3 Sustained release formulation of a peptide
11/01/2001WO2001010847A3 Novel integrin receptor antagonists
11/01/2001WO2000066111A9 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/01/2001US20010036952 Treatment of alopecia
11/01/2001US20010036946 Antiinflammatory agents
11/01/2001US20010036921 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
11/01/2001US20010036456 Administering Protein C
11/01/2001CA2407507A1 Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy
11/01/2001CA2407493A1 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
11/01/2001CA2407449A1 Novel compounds
11/01/2001CA2407445A1 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo¬3,4-b|-pyridines as cyclin dependent kinase inhibitors
11/01/2001CA2407352A1 Compositions and methods for the therapy and diagnosis of acne vulgaris
11/01/2001CA2407093A1 Substituted phenyl farnesyltransferase inhibitors
11/01/2001CA2406855A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001CA2406272A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
11/01/2001CA2406264A1 Protein phosphatases
11/01/2001CA2405170A1 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001CA2402808A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines
10/2001
10/31/2001EP1149903A1 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
10/31/2001EP1149842A2 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
10/31/2001EP1149578A1 Cosmetic or pharmaceutical compositions containing an Argania Spinosa extract
10/31/2001EP1149116A1 Process for the production of multiple cross-linked hyaluronic acid derivatives
10/31/2001EP1149114A2 Polypeptides involved in immune response
10/31/2001EP1149113A1 Use of agonists or antagonists of mip-3a in therapy
10/31/2001EP1149111A1 Method and composition for angiogenesis inhibition
10/31/2001EP1149080A2 Crystalline form of benzoquinoline-3-one derivative as inhibitor of 5-alpha reductase
10/31/2001EP1149072A1 Sulfonamide hydroxamates
10/31/2001EP1149063A2 Ureido-thiobutyric acid derivatives as ppar-agonists
10/31/2001EP1148902A1 Method of enhancing needleless transdermal powdered drug delivery
10/31/2001EP1148886A2 Use of a polyanionic polysaccharide solution for the prevention of abscess formation
10/31/2001EP1148881A1 USE OF PYRIDAZINO 4,5-$i(b)]INDOLE-1-ACETAMIDE DERIVATIVES FOR PREPARING MEDICINES FOR TREATING DISEASES RELATED TO THE DYSFUNCTION OF PERIPHERAL BENZODIAZEPIN RECEPTORS
10/31/2001EP1148875A1 Methods and compositions to enhance white blood cell count
10/31/2001EP0869946B1 Phenylimidazolidines and use thereof as an antiandrogenic agent
10/31/2001EP0800524B1 6-[triazolyl[ 3-(trifluoromethyl)phenyl]methyl]-2-quinolinones and -quinolinethiones
10/31/2001EP0759760B1 Wound healing agent
10/31/2001DE10021246A1 New N-substituted benzamide derivatives are tyrosine kinase KDR and FLT inhibitors useful e.g. for treating tumors, psoriasis, rheumatoid arthritis, diabetic retinopathy or liver sclerosis
10/31/2001DE10019252A1 Polydesoxyribonukleotide zur Hemmung der ICAM-1-Genexpression Polydeoxyribonucleotides to inhibit the ICAM-1 gene expression
10/31/2001DE10019235A1 Neue Flavonglykosid-Derivate für den Einsatz in Kosmetika, Pharmazeutika und Ernährung New flavone derivatives for use in cosmetics, pharmaceuticals and nutrition
10/31/2001DE10019136A1 Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung Polyamide nucleic acid derivatives, means, and methods for their preparation
10/31/2001DE10019135A1 Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung Polyamide nucleic acid derivatives, means, and methods for their preparation
10/31/2001CN1320117A 2-substituted heterocyclic sulfonamides
10/31/2001CN1320116A Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
10/31/2001CN1320042A Seletive treatment of endothelial somatostatin receptors
10/31/2001CN1320039A Reduction of oxidative stress factors
10/31/2001CN1320028A Method of treating hair loss using sulfonamides
10/31/2001CN1319430A Pikang powder medicine for curing dermatosis
10/31/2001CN1319428A Medicinal pillow for treating freckle
10/31/2001CN1319422A Medicine for treating psoriasis
10/31/2001CN1319413A Skin rehabilitation medicine for treating burn and scald
10/31/2001CN1319406A Oral powder medicine Xiaobaisan for treating leukotrichia and its preparation method
10/31/2001CN1319399A Medicine for curing burn and scald
10/31/2001CN1319390A Bath lotion and preparation process thereof
10/31/2001CN1319388A Germinal liniment
10/31/2001CN1073849C Chinese and western medicine capsule for curing psoriasis and leucodermia in sleep
10/30/2001US6310267 Fibrinogen solution is subjected to a single-stage or multistage dialysis, then a flexible fibrin web is formed by action of an aqueous thrombin solution on the fibrinogen solution and this is subsequently subjected to freeze-drying
10/30/2001US6310226 Vitamin D analogues
10/30/2001US6310217 Antiinflammatory and analgesic agents
10/30/2001US6310177 Compounds and methods for modulating tissue permeability
10/30/2001US6310166 Sterilized cyanoacrylate solutions containing thickeners
10/30/2001US6310088 Treating condition associated with matrix metalloproteinases or mediated by tumor necrosis factor-alpha or enzymes involved in shedding l-selectin, cd23, tumor necrosis factor receptors, interleukin-6 receptors or interleukin-1 receptors
10/30/2001US6309877 Polynucleotides encoding motoneuronotrophic factors
10/30/2001US6309856 Human MAD proteins and uses thereof
10/30/2001US6309830 Nucleotide sequence which encodes a synthetic transfer ribonucleic acid; for use as a tool in gene therapy
10/30/2001US6309663 Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
10/30/2001US6309631 Oil-based base cream, 40-50% w/w of a 1:1 w/w mixture of titanium dioxide and ferric oxide and from 0 to 20% w/w of a melt additive; mitigation of burns
10/28/2001CA2345569A1 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
10/25/2001WO2001083485A1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives
10/25/2001WO2001079524A2 Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof
10/25/2001WO2001079487A2 Polydesoxyribonucleotides for inhibiting the expression of the icam-1-gene
10/25/2001WO2001079480A1 Albumin fusion proteins
10/25/2001WO2001079478A1 Factors participating in degranulation of mast cells, dnas encoding the same, method of screening inhibitors of these factors and the inhibitors
10/25/2001WO2001079453A1 Cell culture method, cell cluster obtained by said methods and use thereof
10/25/2001WO2001079444A2 Albumin fusion proteins
10/25/2001WO2001079443A2 Albumin fusion proteins
10/25/2001WO2001079442A2 Albumin fusion proteins
10/25/2001WO2001079288A2 Cytokine uses; compositions; methods
10/25/2001WO2001079284A2 Therapeutic compounds and methods for formulating v3, a versican isoform
10/25/2001WO2001079282A2 Molecules associated with human reproduction
10/25/2001WO2001079271A1 Albumin fusion proteins
10/25/2001WO2001079258A1 Albumin fusion proteins
10/25/2001WO2001079253A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
10/25/2001WO2001079249A2 Peptide nucleic acid derivatives with a negative charge, agents and methods for producing them
10/25/2001WO2001079245A1 Novel flavone glycoside derivatives for use in cosmetics, pharmaceuticals and nutrition
10/25/2001WO2001079216A2 Polyamide nucleic acid derivatives, agents and methods for producing them
10/25/2001WO2001079189A2 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation'
10/25/2001WO2001079184A1 Substituted piperazine compounds
10/25/2001WO2001079180A2 5-substituted tetralones as inhibitors of ras farnesyl transferase
1 ... 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 ... 1065